A similar trend can be observed in pharmacological studies using GSHR ligands, where, without prior stress exposure, GHSR agonists predominantly promote anxiety- and depression-like behaviors, but seem to reduce chronic stress-related phenotypes. Here, GHSR is linked to depressive symptom measurement.